Topic - Paul Cirel

Subscribe to this topic via RSS or ATOM
Related Stories
  • Mass. pharmacy dodged reprimand after protest

    Massachusetts regulators in 2004 proposed a formal reprimand for a company now linked to deadly meningitis outbreak, but they never delivered it after the company protested the reprimand could be "fatal to the business."

  • Investigators visit Mass. firm in meningitis case

    Criminal investigators from the Food and Drug Administration have visited a Massachusetts company whose steroid medication has been linked to a deadly meningitis outbreak.

  • Lawmakers seek Mass. pharmacy Justice Dept. probe

    Two members of Congress have asked the U.S. Department of Justice to investigate whether a specialty pharmacy linked to a nationwide meningitis outbreak violated any federal laws or regulations.

More Stories →

Quotations
  • In a footnote, he wrote, "Once disclosed, the reprimand will surely result in inquiries/investigations in those other jurisdictions. Regardless of the derivative actions taken, the attendant legal and administrative costs will be devastating."

    Mass. pharmacy dodged reprimand after protest →

  • "Such a catastrophe is clearly not the intended result of the Board's proposed reprimand, nor is it warranted in this case," Cirel wrote. "The Board's mandate is to protect the public health safety and welfare, not punish the licensees."

    Mass. pharmacy dodged reprimand after protest →

Happening Now